[1] Li YL, Dang H, Zhang LJ, Li GP, Shan XW, Yuan M, et al. Schistosomiasis surveillance — China, 2015−2018. China CDC Wkly 2020;2(3):39 − 43. http://dx.doi.org/10.46234/ccdcw2020.011CrossRef
[2] Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet 2014;383(9936):2253 − 64. http://dx.doi.org/10.1016/S0140-6736(13)61949-2CrossRef
[3] Deol AK, Fleming FM, Calvo-Urbano B, Walker M, Bucumi V, Gnandou I, et al. Schistosomiasis-assessing progress toward the 2020 and 2025 global goals. N Engl J Med 2019;381(26):2519 − 28. http://dx.doi.org/10.1056/NEJMoa1812165CrossRef
[4] Ekpo UF, Oluwole AS, Abe EM, Etta HE, Olamiju F, Mafiana CF. Schistosomiasis in infants and pre-school-aged children in sub-Saharan Africa: implication for control. Parasitology 2012;139(7):835 − 41. http://dx.doi.org/10.1017/S0031182012000029CrossRef
[5] Pisarski K. The global burden of disease of zoonotic parasitic diseases: top 5 contenders for priority consideration. Trop Med Infect Dis 2019;4(1):44. http://dx.doi.org/10.3390/tropicalmed4010044CrossRef
[6] Wang RB, Wang TP, Wang LY, Guo JG, Yu Q, Xu J, et al. Study on the re-emerging situation of schistosomiasis epidemics in areas already under control and interruption. Chin J Epidemiol 2004;25(7):564 − 7. http://dx.doi.org/10.3760/j.issn:0254-6450.2004.07.004 (In Chinese). CrossRef
[7] Wang LD, Chen HG, Guo JG, Zeng XJ, Hong XL, Xiong JJ, et al. A strategy to control transmission of Schistosoma japonicum in China. N Engl J Med 2009;360(2):121 − 8. http://dx.doi.org/10.1056/NEJMoa0800135CrossRef
[8] Wang TP, Cao ZG, Chen HG, Zhou XN. Changes of control strategy and improvement of schistosomiasis control in China. Chin J Schisto Control 2009;21(4):241 − 2. http://dx.doi.org/10.3969/j.issn.1005-6661.2009.04.001 (In Chinese). CrossRef
[9] Wang TP. Thinking on the control strategy at schistosomiasis elimination stage in China. Chin J Schisto Control 2019;31(4):358 − 61. http://dx.doi.org/10.16250/j.32.1374.2019162 (In Chinese). CrossRef
[10] Hong A, Zampieri RA, Shaw JJ, Floeter-Winter LM, Laranjeira-Silva MF. One health approach to leishmaniases: understanding the disease dynamics through diagnostic tools. Pathogens 2020;9(10):809. http://dx.doi.org/10.3390/pathogens9100809CrossRef
[11] Elelu N, Aiyedun JO, Mohammed IG, Oludairo OO, Odetokun IA, Mohammed KM, et al. Neglected zoonotic diseases in Nigeria: role of the public health veterinarian. Pan Afr Med J 2019;32:36. http://dx.doi.org/10.11604/pamj.2019.32.36.15659CrossRef
[12] Wang W, Bergquist R, King CH, Yang K. Elimination of schistosomiasis in China: current status and future prospects. PLoS Negl Trop Dis 2021;15(8):e0009578. http://dx.doi.org/10.1371/journal.pntd.0009578CrossRef
[13] Yang F, Xu J, Lü S, Cao CL, Li SZ, Zhang LJ. Analysis on epidemiological characteristics of current advanced schistosomiasis cases in China based on the Epidemiological Dynamic Data Collection Platform (EDDC). Chin J Schisto Control 2021;33(3):234 − 9,247. http://dx.doi.org/10.16250/j.32.1374.2021113 (In Chinese). CrossRef
[14] Wang W, Yang K. Implementation of precision control to facilitate the progress towards schistosomiasis elimination in China. China Trop Med 2020;20(7):595 − 8. http://dx.doi.org/10.13604/j.cnki.46-1064/r.2020.07.01 (In Chinese). CrossRef
[15] Hong Z, Wu LL, Wang LP, Xu J. Progress and challenges on global schistosomiasis control. Chin J Parasitol Parasit Dis 2021;39(3):514 − 9. http://dx.doi.org/10.12140/j.issn.1000-7423.2021.04.015 (In Chinese). CrossRef